On the eve of the Olympics' opening ceremony in Rio de Janeiro, there's good news on combating the Zika virus: a promising vaccine effective in monkeys and now being fast-tracked for human clinical trials.
A purified, inactivated Zika virus vaccine earlier found to work in mice is effective against Brazilian and Puerto Rican strains of the virus in monkeys, too, researchers from the Walter Reed Army Institute of Research and Harvard Medical School reported in a study out on Thursday in the journal Science.
Phase 1 clinical testing of the vaccine, developed by the Walter Reed Institute, is expected to start in October.
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
